- "It was one of the most horrific accidents I have ever seen": Suspected DUI head-on collision kills 6
- NHL roundup: Skinner’s hat trick leads Sabres in rout
- NFL notebook: Gronk’s chances of playing Sunday look grim
- MLB notebook: Sale blames belly ring for illness
- Student Loans Are Derailing Millennials' Savings Efforts
FILE PHOTO – Shoppers walk outside a CVS store and pharmacy in Medford, Massachusetts, U.S. December 4, 2017. REUTERS/Brian Snyder
October 10, 2018
WASHINGTON (Reuters) – Pharmacy chain CVS Health Corp won U.S. antitrust approval for its $69 billion acquisition of health insurer Aetna Inc, the Justice Department said on Wednesday, paving the way for a combination the companies say can help cut soaring U.S. healthcare costs.
It is the second large recent healthcare deal to win antitrust approval from the U.S. Justice Department. The agency gave the green light to health insurer Cigna Corp’s $52 billion acquisition of the nation’s largest pharmacy benefit manager, Express Scripts Holding Co, on Sept. 17.
(Reporting by Diane Bartz; Editing by Bill Berkrot)